KLK3 and prostate cancer: In conclusion, our study confirms better FFS for WPRT but shows that SBRT may be used in some prostate cancer nodal recurrences, particularly in patients with initial Gleason < 8, low PSA at recurrence, and long PSA doubling time at recurrence.